Section Arrow
IRIX.NASDAQ
- IRIDEX Corp
(Financial Status)
Quotes are at least 15-min delayed:2026/11/20 17:46 EST
After Hours
Last
 0.4348
-0.01015 (-2.28%)
Bid
0.4202
Ask
0.4999
High 0.4348 
Low 0.4348 
Volume 24 
Regular Hours (Closed)
Last
 0.44495
-0.02135 (-4.58%)
Day High 
0.478 
Prev. Close
0.4663 
1-M High
0.8355 
Volume 
48.76K 
Bid
0.4202
Ask
0.4999
Day Low
0.42955 
Open
0.478 
1-M Low
0.45 
Market Cap 
8.19M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.65 
20-SMA 0.69 
50-SMA 0.7 
52-W High 1.6481 
52-W Low 0.45 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.19/--
Enterprise Value
12.02M
Balance Sheet
Book Value Per Share
-0.19
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
52.68M
Operating Revenue Per Share
3.21
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.5 +0.52 +1.24%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.66 +0.03 +1.84%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.92 +0.011 +1.21%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 104.33 +1.33 +1.29%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.